Bryce Johnson, MD and colleagues aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.
Bryce Johnson, MD and colleagues aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.
Bryce Johnson, MD and colleagues...